Risk factors for microvascular tumour thrombi in hepatocellular carcinoma: a univariate and multivariate analysis

ANZ J Surg. 2007 Mar;77(3):146-9. doi: 10.1111/j.1445-2197.2006.03995.x.

Abstract

Background: Microvascular tumour thrombi in hepatocellular carcinoma (HCC) predict poor outcome and are a risk factor for intrahepatic and extrahepatic metastases. Survival after liver transplantation is also affected. Our aim was to predict the risk factors for the presence of microvascular tumour thrombi.

Methods: Seventy-six patients who had undergone hepatectomy for HCC in our hospital were included in a retrospective analysis from a prospective database.

Results: Thirty-one patients (40.8%; mean age 50.7 +/- 12.2 years, P < 0.021) had microvascular tumour thrombi (group T) and 54 patients (group NT; mean age 58.6 +/- 15.4 years) did not. Using logistic regression analysis, we found that more than one HCC nodule, a large tumour, chronic hepatitis C infection and high serum aspartate aminotransferaselevels were significant risk factors for microvascular tumour thrombi. Age, preoperative serum bilirubin level and sex were not significant risk factors.

Conclusion: Patients with chronic hepatitis C infection having multiple HCC nodules, large tumour size and high preoperative aspartate aminotransferase levels are at high risk for microvascular tumour thrombi.

MeSH terms

  • Adult
  • Aged
  • Analysis of Variance
  • Aspartate Aminotransferases / blood
  • Carcinoma, Hepatocellular / blood
  • Carcinoma, Hepatocellular / etiology
  • Carcinoma, Hepatocellular / pathology*
  • Carcinoma, Hepatocellular / surgery
  • Female
  • Hepatectomy
  • Hepatitis C, Chronic / complications
  • Humans
  • Liver Neoplasms / blood
  • Liver Neoplasms / etiology
  • Liver Neoplasms / pathology*
  • Liver Neoplasms / surgery
  • Male
  • Microcirculation
  • Middle Aged
  • Neoplastic Cells, Circulating / pathology*
  • Retrospective Studies
  • Risk Factors

Substances

  • Aspartate Aminotransferases